EPCAM and Familial prostate cancer: In this study, we constructed a CAR targeting the cancer stem cell marker EpCAM and demonstrated that human PBLs transduced with the EpCAM-specific CAR can kill the prostate cancer cells PC3M and PC3, both in vitro and in vivo.